Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
暂无分享,去创建一个
S. Larson | R. Tuttle | K. Pentlow | R. Robbins | R. Leboeuf | R. Qualey | C. Y. Chan | C. Chan
[1] S. Larson,et al. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] V. R. McCready,et al. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. , 1984, The British journal of radiology.
[3] S. Mandel,et al. Radioactive iodine and the salivary glands. , 2003, Thyroid : official journal of the American Thyroid Association.
[4] R. Leeper. The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. , 1973, The Journal of clinical endocrinology and metabolism.
[5] B. Caillou,et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. , 1986, The Journal of clinical endocrinology and metabolism.
[6] S. Larson,et al. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] S. M. Seidlin,et al. Radioactive iodine therapy: Effect on functioning metastases ofadenocarcinoma of the thyroid , 1990, CA: a cancer journal for clinicians.
[8] E. Coche,et al. Iodine metabolism in severe renal insufficiency. , 1969, The Journal of clinical endocrinology and metabolism.
[9] W. Beierwaltes. The treatment of thyroid carcinoma with radioactive iodine. , 1978, Seminars in nuclear medicine.
[10] M. Schlumberger,et al. The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma , 2005 .
[11] B. Shapiro,et al. Radionuclide diagnosis and therapy of thyroid cancer: current status report. , 1985, Seminars in nuclear medicine.
[12] J G Kereiakes,et al. In vivo quantitation of lesion radioactivity using external counting methods. , 1976, Medical physics.
[13] Howard S. Smith,et al. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. , 1990, Endocrinology and metabolism clinics of North America.
[14] W. Huang,et al. Radioiodine I-131 therapy in the management of differentiated thyroid carcinoma: a review of 202 patients. , 1993, Journal of the Formosan Medical Association = Taiwan yi zhi.
[15] R. Wahl,et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. , 2006, The Journal of clinical endocrinology and metabolism.
[16] W. Blahd,et al. Radioiodine I‐131 therapy in the management of thyroid cancer. A prospective study , 1977 .
[17] Gerard M Doherty,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[18] R. Tuttle,et al. Radioiodine Dosimetry with Recombinant Human Thyrotropin , 2006 .
[19] P DESAIVE,et al. [Thyroid cancer]. , 1951, Revue medicale de Liege.
[20] D. van Nostrand,et al. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. , 2002, Thyroid : official journal of the American Thyroid Association.
[21] M. Sonenberg,et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.
[22] T. Petrich,et al. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age , 2001, European Journal of Nuclear Medicine.
[23] E. Hindié,et al. Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[24] H. Biersack,et al. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] J. Sisson. Practical dosimetry of 131I in patients with thyroid carcinoma. , 2002, Cancer biotherapy & radiopharmaceuticals.